ABT · SUB · PE · INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «ABBOTT LABORATORIOS SA» ↔ SEC ABT (CIK 1800, ABBOTT LABORATORIES): 6 non-competitive contracts at the buyer «INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS», 5,576,282 PEN (≈ $1,505,596); one bid, method direct (Contratación Directa), method «Adjudicación de Menor Cuantía»; OCID ocds-dgv273-seacev3-726207, ocds-dgv273-seacev3-737448, ocds-dgv273-seacev3-770429, ocds-dgv273-seacev3-131801, ocds-dgv273-seacev3-877778, ocds-dgv273-seacev3-27652; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

ABT · SUB · PE · INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

1,505,596

Records behind the indicator

6

Found

4 October 2026

Code

W-02083

Reference

ocds-dgv273-seacev3-726207

Reference

ocds-dgv273-seacev3-737448

Reference

ocds-dgv273-seacev3-770429

Reference

ocds-dgv273-seacev3-131801

Reference

ocds-dgv273-seacev3-877778

Reference

ocds-dgv273-seacev3-27652